Medtronic Balance Sheet Analysis
MDT Stock | USD 80.57 1.09 1.37% |
Medtronic |
Most accounts from Medtronic PLC's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Medtronic PLC current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Medtronic PLC Valuation and Medtronic PLC Correlation analysis. For more information on how to buy Medtronic Stock please use our How to Invest in Medtronic PLC guide.At this time, Medtronic PLC's Non Current Assets Total are comparatively stable compared to the past year. Non Currrent Assets Other is likely to gain to about 2.8 B in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 1.2 B in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 24.1B | 24.4B | 28.0B | 29.4B | Total Assets | 91.0B | 90.9B | 104.6B | 109.8B |
Medtronic PLC balance sheet Correlations
Click cells to compare fundamentals
Medtronic PLC Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Medtronic PLC balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 90.7B | 93.1B | 91.0B | 90.9B | 104.6B | 109.8B | |
Other Current Liab | 5.6B | 6.1B | 6.1B | 6.1B | 7.0B | 7.3B | |
Net Debt | 20.7B | 22.8B | 20.4B | 22.8B | 26.2B | 27.6B | |
Retained Earnings | 28.1B | 28.6B | 30.3B | 30.4B | 35.0B | 36.7B | |
Cash | 4.1B | 3.6B | 3.7B | 1.5B | 1.8B | 1.6B | |
Net Receivables | 4.6B | 5.5B | 5.6B | 6.0B | 6.9B | 7.2B | |
Inventory | 4.2B | 4.3B | 4.6B | 5.3B | 6.1B | 6.4B | |
Other Current Assets | 2.2B | 2.0B | 2.3B | 2.4B | 2.8B | 2.9B | |
Total Liab | 39.8B | 41.5B | 38.3B | 39.3B | 45.2B | 47.4B | |
Total Current Assets | 22.0B | 22.5B | 23.1B | 21.7B | 24.9B | 26.2B | |
Short Term Debt | 2.8B | 11M | 3.7B | 20M | 23M | 21.9M | |
Intangible Assets | 19.1B | 17.7B | 15.6B | 14.8B | 17.1B | 17.9B | |
Accounts Payable | 2.0B | 2.1B | 2.3B | 2.7B | 3.1B | 3.2B | |
Other Liab | 6.7B | 5.8B | 5.5B | 6.8B | 7.8B | 3.9B | |
Other Assets | 2.1B | 3.5B | 1M | (1M) | (1.2M) | (1.1M) | |
Long Term Debt | 22.0B | 26.4B | 20.4B | 24.3B | 28.0B | 29.4B | |
Good Will | 39.8B | 42.0B | 40.5B | 41.4B | 47.6B | 50.0B | |
Common Stock | 134.1K | 134.5K | 133.1K | 133.1K | 119.8K | 113.8K | |
Short Long Term Debt | 2.8B | 11M | 3.7B | 20M | 18M | 17.1M | |
Net Tangible Assets | 50.7B | (8.3B) | (3.5B) | 51.5B | 59.2B | 62.2B |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Medtronic PLC Valuation and Medtronic PLC Correlation analysis. For more information on how to buy Medtronic Stock please use our How to Invest in Medtronic PLC guide.Note that the Medtronic PLC information on this page should be used as a complementary analysis to other Medtronic PLC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Complementary Tools for Medtronic Stock analysis
When running Medtronic PLC's price analysis, check to measure Medtronic PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medtronic PLC is operating at the current time. Most of Medtronic PLC's value examination focuses on studying past and present price action to predict the probability of Medtronic PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medtronic PLC's price. Additionally, you may evaluate how the addition of Medtronic PLC to your portfolios can decrease your overall portfolio volatility.
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |
Is Medtronic PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medtronic PLC. If investors know Medtronic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medtronic PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.078 | Dividend Share 2.75 | Earnings Share 3.15 | Revenue Per Share 24.298 | Quarterly Revenue Growth 0.047 |
The market value of Medtronic PLC is measured differently than its book value, which is the value of Medtronic that is recorded on the company's balance sheet. Investors also form their own opinion of Medtronic PLC's value that differs from its market value or its book value, called intrinsic value, which is Medtronic PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medtronic PLC's market value can be influenced by many factors that don't directly affect Medtronic PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medtronic PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medtronic PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medtronic PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.